Increased membrane cholesterol in CD8+ T-cells by pharmacologic and genetic blockades of ACAT1 improves TCR clustering and signaling, that enhances proliferation and killing function in murine tumor models [91]. The gene discussed is CD8A; the disease is neoplasm.